The Filing Desk

Beta Bionics vs NeuroPace

Beta Bionics BBNX · NeuroPace NPCE · Health Care Equipment

Beta Bionics reported revenue of $100 million in fiscal 2025, about the same as NeuroPace's $100 million in fiscal 2025. Beta Bionics' revenue grew 53.9% in its latest year, and NeuroPace's grew 25.1%. Beta Bionics had an operating margin of -71.5%, against -16.3% at NeuroPace. Free cash flow was −$56 million at Beta Bionics and −$11 million at NeuroPace.

Side by side

Beta BionicsNeuroPace
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$100M$100M
Revenue growth53.9%25.1%
Revenue growth a year, last 5 years—19.5%
Gross margin55.4%77.2%
Operating margin−71.5%−16.3%
Net margin−73.0%−21.5%
Free cash flow−$56M−$11M
Free cash flow margin−56.1%−11.3%
Return on capital—−81.8%
Net debt to EBITDA——
Dividends and buybacks$0M$50M
Change in diluted share count536.7%12.3%
Last close$13.32$8.14
P/E at the last close——
Insider trades, last 12 monthssold $4.5 millionbought $302,102, sold $399,250
Piotroski F-score—5 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Beta BionicsNeuroPace
Operating margin
Percent of revenue
Beta BionicsNeuroPace
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Beta BionicsNeuroPace

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Beta Bionics and NeuroPace pages.